Top 44 Strain UK

body {
font-family: Arial, sans-serif;
line-height: 1.6;
max-width: 900px;
margin: 0 auto;
padding: 20px;
color: #333;
}
h1 {
color: #1a5f2d;
border-bottom: 3px solid #1a5f2d;
padding-bottom: 10px;
}
h2 {
color: #2d7a3f;
margin-top: 25px;
}
table {
width: 100%;
border-collapse: collapse;
margin: 20px 0;
background-color: #f9f9f9;
}
th, td {
border: 1px solid #ddd;
padding: 12px;
text-align: left;
}
th {
background-color: #1a5f2d;
color: white;
}
tr:nth-child(even) {
background-color: #f0f8f4;
}
.note {
background-color: #e8f5e9;
border-left: 4px solid #1a5f2d;
padding: 15px;
margin: 15px 0;
}

Top 44 Medical Cannabis Strain Guide for UK Patients

Genetics and Origin

Top 44 is an award-winning hybrid cannabis strain with a fascinating pedigree. This strain was developed through careful crossbreeding of predominantly Indica genetics with select Sativa traits, creating a balanced hybrid that appeals to medical users seeking both symptom relief and functional clarity. The exact parentage remains proprietary to breeders, though the strain exhibits characteristics consistent with classic North American breeding programmes. Top 44 has gained significant recognition in medical cannabis circles for its stable genetics and consistent cannabinoid profiles, making it a reliable choice for pharmaceutical-grade production in licensed facilities.

Cannabinoid Profile

Top 44 typically delivers a moderate THC concentration ranging from 12 to 18 percent, making it accessible for patients new to cannabis therapy whilst providing meaningful therapeutic effects for experienced users. The CBD content remains relatively modest at 0.3 to 1.5 percent, though this minor cannabinoid contributes to the entourage effect that enhances overall therapeutic benefit. The THC-dominant profile makes Top 44 particularly suitable for pain management and mood regulation, whilst the minor cannabinoids and terpene profile provide additional neuroprotective and anti-inflammatory properties.

Effects and Experience

Users report balanced effects that begin with a gentle cerebral uplift, gradually transitioning into a profound body relaxation. Many patients describe Top 44 as a “clear-headed” experience, allowing mental acuity whilst addressing physical discomfort. The onset typically occurs within 15-20 minutes when vaporised, with effects peaking at one to two hours. Unlike some Indica-dominant strains, Top 44 avoids excessive sedation for most users, making it suitable for daytime use in lower doses and evening use at higher doses. The flavour profile features earthy undertones complemented by subtle fruity notes and a hint of pine, creating an enjoyable sensory experience.

Medical Applications

Top 44 demonstrates particular efficacy for several medical conditions commonly treated within the UK private cannabis access scheme. Chronic pain patients benefit significantly from its potent analgesic properties, whilst individuals managing anxiety disorders appreciate its anxiolytic effects without pronounced sedation. The strain shows promise for insomnia and sleep disturbances, particularly when used in the evening. Patients experiencing cancer-related symptoms, including nausea and appetite loss, report positive outcomes. Additionally, Top 44 may benefit those managing multiple sclerosis-related muscle spasticity and inflammatory conditions.

Availability in UK Pharmacies

Top 44 is available through several licensed UK cannabis providers operating under the private prescription framework established in 2018. Clinics including Sapphire, Dispensary Green, and Releaf review may stock this strain in dried flower, oil, or cartridge formats. Availability varies by supplier and stock levels fluctuate regularly. Patients require a prescription from a specialist consultant registered with the General Medical Council. Expect to pay £8-12 per gram for dried flower through licensed dispensaries. Availability through NHS prescription remains extremely limited, confined to specific conditions under the 2018 regulations.

Growing Information

Home cultivation remains illegal in the United Kingdom. However, understanding cultivation requirements aids patient appreciation of laboratory-grown medical cannabis. Top 44 thrives in controlled indoor environments with 18-hour photoperiods during vegetative growth. The strain exhibits moderate height, reaching approximately 90-120cm indoors, making it suitable for space-conscious cultivators. Flowering requires 8-9 weeks with 12-hour photoperiods. The strain demonstrates resilience against common pests and moulds, though maintaining optimal humidity levels (40-50% during flowering) remains essential. Yields typically reach 400-500g per square metre under professional conditions.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medical cannabis is a prescription-only medicine in the UK. Always consult a qualified healthcare professional. CannaZen is an information platform, not a medical provider.